EP4427775A3 — An injection device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2024-11-20 · 1y expired
What this patent protects
A supplemental device for attachment to an injection device, the supplemental device comprising: a housing (10) containing magnetic sensors, each of the magnetic sensors being configured to change state based on a sensed magnetic field when a rotatable surface of the injection d…
USPTO Abstract
A supplemental device for attachment to an injection device, the supplemental device comprising: a housing (10) containing magnetic sensors, each of the magnetic sensors being configured to change state based on a sensed magnetic field when a rotatable surface of the injection device moves rotationally and axially with respect to a housing of the injection device; and a processor arrangement configured to: detect the change in the state of each of the magnetic sensors; and determine a number of dosage units from the detected change in state of each of the magnetic sensors.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.